Clinical Trial: Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational




Official Title: Evaluation of a Novel Method of Contrast Volume Quantification - The AVERT PLUS

Brief Summary:

Purpose: To evaluate the accuracy of the AVERT PLUS to monitor contrast volume used during angiographic procedures.

Research Design: The AVERT PLUS is an FDA 510K cleared device which consists of a contrast delivery modulator designed to reduce unnecessary contrast dye delivery to the patient during angiography (coronary or peripheral) and a concomitant system to precisely measure contrast volume delivered to the patient. This will be a first in man prospective observational study of the accuracy of this system to quantify contract volume used during clinically indicated angiography in the cardiac catheterization laboratory.